PA-824
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PA-824, covering 2016-01-14 to 2023-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Assessing PA-824 for Tuberculosis (the APT Trial) [Phase 2]